Oncolytic Immunotherapy - Robert H Andtbacka Published 2015-07-14 Download video MP4 360p Recommendations 27:56 TIL and Adoptive Therapy - Mark B Faries MD 20:34 Role of Circulating Tumor Cells/DNA & Liquid Biopsy in Melanoma - David Polsky 50:50 silas gaming playing fortnite with viewers 01:23 Oncolytic Virus Therapy: Dynamite for Cancer Cells 21:30 Adjuvant Treatment for Melanoma Dr. Alexandra Gangi 17:40 What happens to lonely people under anesthesia? 49:00 Mast Cell Activation Syndrome (MCAS) 22:56 Waking up during surgery? The truth about general anesthesia & how awareness is prevented 27:28 AMD Revisited: The Other Faces of AMD 18:18 Dyslipidemia – Why Statins Don’t Work in CKD 19:58 Gastrointestinal Concerns in HSD and EDS - Dr. Laura Pace - 2022 45:20 "Fibromyalgia: A Unifying Theory" Dr. Andrew J. Holman 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 03:07 How does CAR T cell therapy work? 1:00:26 Uveitis Presentations 49:41 2015 Atrial Fibrillation Patient Conference: Overview of Afib: John D. Day, MD, FHRS 46:45 Management of Gastrointestinal Symptoms in Dysautonomia - Laura Pace, MD, PhD 22:13 Dr. Ken Berry presentation: Principles of a Proper Human Diet 39:01 "Chronic Fatigue Syndrome: A Unifying Theory" Charles Lapp, M.D. 50:50 "But I still can't see," A Case of Functional Visual Loss? Similar videos 00:47 Dr. Andtbacka on Ongoing Trials with Oncolytic Immunotherapies in Melanoma 06:41 Oncolytic Immunotherapy in Metastatic Melanoma 01:25 Oncolytic Virus-Mediated Immunotherapy: A Combinatorial Approach for Cancer Treatment 01:41 Dr. Robert Andtbacka on Talimogene Laherparepvec in Melanoma 02:48 The use of oncolytic viruses to activate the immune system and help treat melanoma 01:37 Dr. Andtbacka on Optimal Use of T-VEC in Melanoma 01:52 Dr. Andtbacka on the OPTiM Results of T-VEC for Melanoma 01:29 Dr. Robert Andtbacka Reviews the Efficacy of T-VEC in Advanced Melanoma 29:20 Melanoma Skin Trial - Robert Andtbacka 20:11 Taking Aim and Fighting Back- Oncolytic Immunotherapy 06:12 Advances in intratumoral therapy and an update on the BDB001-102 trial 02:34 Dr. Robert Andtbacka Discusses OS With T-VEC in Melanoma 01:52 Robert Andtbacka Discusses T-VEC Trials 01:16 Dr. Robert Andtbacka Discusses T-VEC Plus Ipilimumab in Unresected Melanoma 02:02 Robert Andtbacka on Pre- and Post-Surgical Considerations for Patients with Melanoma 21:23 Oncolytic Virotherapy and Angiogenesis Inhibitors for Skull Base Tumors 02:14 The use of neoadjuvant studies to prevent melanoma from recurring 02:32 OPTiM trial update: T-VEC for the treatment of melanoma 01:58 Dr. John Bell - Use of Oncolytic Viruses More results